Actually, with vaccination, the typical default stance from pretty much anywhere in the medical community is going to be “better safe than sorry”. In other words, unless there is solid, definitive evidence against vaccinating someone who’s had COVID-19 previously, the default answer is going to be to go ahead and do it, particularly for those who had mild or asymptomatic COVID-19.
I would argue that given the evidence coming from Brazil and South Africa on reinfection with certain variants, it may still be beneficial to keep vaccines available to those who had mild or asymptomatic COVID-19. Particularly when the new “boosters” (which aren’t boosters since they’re targeting a slightly modified antigen) become available.
I prefer my doctors "err on the side of caution", myself, since we're throwing out cliches, in lieu of thought.
I would argue...
Well, that ain't no lie.
